Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Olson

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cancers|May 28, 2022
Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce A "Hot" Tumor Microenvironment That Is Responsive to ImmunotherapyRobin Reschke, Daniel J Olson
Cancers|March 28, 2024
Correction: Reschke, R.; Olson, D.J. Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce a "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy. <i>Cancers</i> 2022, <i>14</i>, 2458Robin Reschke, Daniel J Olson
JCO Oncology Practice|June 26, 2026
Timing Is Not Everything: Reassessing Chrono-Immunotherapy in Clinical PracticeReid Shaw, Daniel J Olson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2023
Adoptive Cell Therapy for Nonhematologic Solid TumorsDaniel J Olson, Kunle Odunsi
Future Oncology (London, England)|May 11, 2022
A plain language summary from pembrolizumab plus ipilimumab following PD-1 antibody failure in melanomaDaniel J Olson, Jason J Luke
Oncoscience|July 18, 2020
Improving therapy in metastatic uveal melanoma by understanding prior failuresDaniel J Olson, Jason J Luke
Immunotherapy|February 8, 2019
The T-cell-inflamed tumor microenvironment as a paradigm for immunotherapy drug developmentDaniel J Olson, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2023
Myeloid Maturity: ATRA to Enhance Anti-PD-1?Daniel J Olson, Jason J Luke
Phonetica|March 2, 2026
Phonetic outcomes in Mandarin-English code-switching: exploring the role of orthographic depthYi-Fang Cheng, Daniel J Olson
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|February 2, 2019
Challenges and Perspectives to the Fall in Psychiatry Fellowship ApplicationsJames R Agapoff Iv, Daniel J Olson
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cancers|May 28, 2022
Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce A "Hot" Tumor Microenvironment That Is Responsive to ImmunotherapyRobin Reschke, Daniel J Olson
Cancers|March 28, 2024
Correction: Reschke, R.; Olson, D.J. Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce a "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy. <i>Cancers</i> 2022, <i>14</i>, 2458Robin Reschke, Daniel J Olson
JCO Oncology Practice|June 26, 2026
Timing Is Not Everything: Reassessing Chrono-Immunotherapy in Clinical PracticeReid Shaw, Daniel J Olson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2023
Adoptive Cell Therapy for Nonhematologic Solid TumorsDaniel J Olson, Kunle Odunsi
Future Oncology (London, England)|May 11, 2022
A plain language summary from pembrolizumab plus ipilimumab following PD-1 antibody failure in melanomaDaniel J Olson, Jason J Luke
Oncoscience|July 18, 2020
Improving therapy in metastatic uveal melanoma by understanding prior failuresDaniel J Olson, Jason J Luke
Immunotherapy|February 8, 2019
The T-cell-inflamed tumor microenvironment as a paradigm for immunotherapy drug developmentDaniel J Olson, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2023
Myeloid Maturity: ATRA to Enhance Anti-PD-1?Daniel J Olson, Jason J Luke
Phonetica|March 2, 2026
Phonetic outcomes in Mandarin-English code-switching: exploring the role of orthographic depthYi-Fang Cheng, Daniel J Olson
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|February 2, 2019
Challenges and Perspectives to the Fall in Psychiatry Fellowship ApplicationsJames R Agapoff Iv, Daniel J Olson
Pageof 4